BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
4.760
+0.090 (1.93%)
Jun 17, 2025, 12:06 PM - Market open
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $21.17 million as of June 17, 2025. Its market cap has decreased by -62.26% in one year.
Market Cap
21.17M
Enterprise Value
7.75M
1-Year Change
-62.26%
Ranking
Category
Stock Price
$4.76
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $21.17M, a decrease of -37.37%. That is a compound annual growth rate of -2.90%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.99B |
| Johnson & Johnson | 373.47B |
| Novo Nordisk | 343.59B |
| AbbVie | 337.14B |
| UnitedHealth Group | 279.09B |
| Abbott Laboratories | 233.16B |
| Novartis AG | 232.80B |
| AstraZeneca | 228.09B |